Profil
Mr. Mahn-Soon Hwang is a Chief Executive Officer at Korea Investment Partners Co., Ltd. He is on the Board of Directors at Bio-Synectics, Inc., BioInfra Life Science, Inc. and Xcell Therapeutics, Inc. Mr. Hwang was previously employed as a Non-Executive Director by EyeGene, Inc., a Non-Executive Director by NGeneBio Co., Ltd., a Non-Executive Director by ASTA Co., Ltd., a Non-Executive Director by Bio Solution Co., Ltd., a Non-Executive Director by CTC Bio, Inc., a Non-Executive Director by GENEMATRIX, Inc., an Independent Director by Kainos Medicine, Inc. /old/, a Portfolio Manager by Korea Biotech Investment Capital Co., Ltd., a Non-Executive Director by PCL, Inc., and a Non-Executive Director by TiumBio Co., Ltd. He received his undergraduate degree from Seoul National University and a graduate degree from Seoul National University.
Postes actifs de Mahn-Soon Hwang
| Sociétés | Poste | Début |
|---|---|---|
| BIO-SYNECTICS, INC. | Directeur/Membre du Conseil | 01/01/2009 |
| BIOINFRA LIFE SCIENCE INC. | Directeur/Membre du Conseil | - |
| XCELL THERAPEUTICS INC. | Directeur/Membre du Conseil | - |
Korea Investment Partners Co., Ltd.
Korea Investment Partners Co., Ltd. Investment ManagersFinance Korea Investment Partners invests in companies located in South Korea. The firm focuses on biotech & healthcare, interactive contents & media, consumer internet & fintech, ICT & digitalization, and semiconductor & industrial sectors. It provides financing for early and growth capital requirements. | Directeur Général | - |
Anciens postes connus de Mahn-Soon Hwang
| Sociétés | Poste | Fin |
|---|---|---|
| TIUMBIO CO., LTD. | Directeur/Membre du Conseil | 28/03/2024 |
| NGENEBIO CO., LTD. | Directeur/Membre du Conseil | 31/03/2023 |
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Engages in the research and development of new drugs for cancer and infectious disease | Directeur/Membre du Conseil | 17/11/2016 |
| PCL, INC. | Directeur/Membre du Conseil | - |
| GENEMATRIX INC. | Directeur/Membre du Conseil | - |
Formation de Mahn-Soon Hwang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
CTC Bio, Inc.
CTC Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells veterinary and human drug products | Health Technology |
Korea Investment Partners Co., Ltd.
Korea Investment Partners Co., Ltd. Investment ManagersFinance Korea Investment Partners invests in companies located in South Korea. The firm focuses on biotech & healthcare, interactive contents & media, consumer internet & fintech, ICT & digitalization, and semiconductor & industrial sectors. It provides financing for early and growth capital requirements. | Finance |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Korea Biotech Investment Capital Co., Ltd.
Korea Biotech Investment Capital Co., Ltd. Investment ManagersFinance KBIC's investment strategy focuses on long-term growth opportunities in start-ups operating in the knowledge and technology intensive biotechnology industries and life sciences field. They seek to create significant profits through their portfolio firms. The firm leverages their parent firm's research and industry expertise for the benefit of their investments. | Finance |
Bio Solution Co., Ltd.
Bio Solution Co., Ltd. BiotechnologyHealth Technology Develops cell therapy products and stem cell applied technologies | Health Technology |
GENEMATRIX, Inc.
GENEMATRIX, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs and diagnostics | Commercial Services |
EyeGene, Inc.
EyeGene, Inc. BiotechnologyHealth Technology Develops pharmaceutical and other biological products | Health Technology |
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Engages in the research and development of new drugs for cancer and infectious disease | Health Technology |
ASTA Co., Ltd.
ASTA Co., Ltd. Medical SpecialtiesHealth Technology Develops medical diagnostic systems | Health Technology |
PCL, Inc.
PCL, Inc. Medical SpecialtiesHealth Technology Engages in the manufacturing of medical devices | Health Technology |
Bio-Synectics, Inc.
Bio-Synectics, Inc. Pharmaceuticals: MajorHealth Technology Develops nanoparticle formulations, drug delivery systems and cosmetic ingredients | Health Technology |
Bioinfra Life Science, Inc.
Bioinfra Life Science, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical instrumemts | Health Technology |
NGeneBio Co., Ltd.
NGeneBio Co., Ltd. BiotechnologyHealth Technology Develops vitro and companion diagnostics & software solutions | Health Technology |
TiumBio Co., Ltd.
TiumBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and manufacture of therapeutic drugs | Health Technology |
Xcell Therapeutics, Inc.
Xcell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development and production of cell culture media suitable for advanced biopharmaceuticals | Health Technology |
















